Diabetes

(1050) "Pharmacist-led Automated Insulin Delivery with Structured Education in Underserved Diabetes Patients: Impact on A1C Reduction”

(1052) Addressing Sociocultural Barriers to Medication Adherence: A Randomized Feasibility Pilot Trial of a Tailored Peer Support and Self-management Intervention for Black Adults with Type 2 Diabetes

(1054) Assessing Outcomes Related to Glucagon-like Peptide 1 Interclass Switch in Patients with Diabetes

(1055) Assessing Provider's Perceptions of Metformin Place in Therapy with Growing Utilization of GLP-1 Receptor Agonist and SGLT-2 Inhibitors and Prescribing Patterns

(1056) Assessment of an Educational Program for Community-based Pharmacists Measuring Their Comfortability Counseling Patients and Understanding on Continuous Glucose Monitoring Devices: A Pre-post Study

(1057) Barriers and Facilitators to Translating the Diabetes Prevention Program in Rural Church Settings: Perspectives of Church Leaders and Lifestyle Coaches

(1058) Bridging Technology and Patient Care: Investigating the Role of Continuous Glucose Monitoring (CGM) in Influencing Health Perspectives of Those Living with Type II Diabetes

(1059) Clinical Decision Making Utilizing Continuous Glucose Monitor Data: How Well Does It Correlate to hba1c?

(1060) Community-pharmacy Resident Led Diabetes Injection Technique Education and Disease State Optimization

(1062) Diabetes Distress Scores in English versus Non-english Speaking Type 2 Diabetes Patients

(1063) Evaluating the Impact of an Educational Intervention on Pharmacists Confidence with Counseling on Continuous Glucose Monitor Use and Prescribing

(1064) Evaluation of a Pharmacist’s Impact on the Utilization of Continuous Glucose Monitor for Diabetes Management in a Primary Care Setting

(1065) Evaluation of the Impact of Community Pharmacist Nutrition Focused Educational Intervention to Increase Patient Adherence to Diabetes Medications and Decrease Self-reported Adverse Effects

(1066) Evaluation of the Initiation of a Pharmacist-led Professional Continuous Glucose Monitoring (CGM) Program

(1068) Identifying Social Determinants of Health During Pharmacy-led Blood Glucose Screening and Testing for T2DM or Pre-diabetes at Community Events

(1070) Impact of Pharmacist Intervention on Achieving Goal Time in Range in the Primary Care Setting

(1071) Impact of Pharmacist-led Continuous Glucose Monitoring Program on Reduction in a1c in an FQHC

(1072) Impact of Pharmacist-physician Collaboration on Diabetic Clinical Outcomes in Federally Qualified Health Centers

(1073) Implementation and Evaluation of a Pharmacist-led Glucagon-like peptide-1 Receptor Agonist Titration Service in a Primary Care Clinic

(1075) Long-term Effect of Pharmacist-led Interventions on Diabetes Distress Among People with Type 2 Diabetes in a Community Care Setting

(1076) Pharmacist Impact on Continuous Glucose Monitoring Utilization in Family Medicine, Graduate Medical Education Clinics

(1077) Real-world Glycemic Outcomes of >3,200 Adults with Type 2 Diabetes Using the Omnipod® 5 Automated Insulin Delivery (AID) System with Cloud-based Data Management

(1078) Sustaining Diabetes-related Services in Pharmacy Settings: How Pharmacy and Public Health Partnerships Make a Difference

(1079) The Impact of Expanded Eligibility Criteria on Patients’ Access to Continuous Glucose Monitors and a1c Outcomes at a Federally Qualified Health Center

(1080) Therapeutic Inertia in Diabetes Care Management: A Retrospective Comparative Study of Specialty Clinics and Standard of Care

(1081) Unmet Needs with Current Basal Insulin Therapy: Insights from US Healthcare Professionals (HCPs)